Calliditas Therapeutics (CALT)
$0.00 $0.00 (0.00%) 10:16 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.10B -
Day's Range
- - - -
Volume
7,684 -
52 Week Low / High
$16.00 - $43.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CALT's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $51.80
- Target Price
Company News
-
Calliditas Therapeutics provides business update ahead of JP Morgan conference — Jan 8th, 2024
STOCKHOLM, Jan. 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today provided a business update for the fourth quarter of 2023 and certain preliminary, unaudited key financial informatio...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$